If ACL is currently only valued on the Synthetic Heparin (which it is) then what value willbe place on HyCamp? ACL are off to ASCO to generate support for a Phase 3 FDA submission and based on their results they should get it.
Also,the HyAct platform has scope beyond the current trial area so it will be interesting to see how it gets valued now that the results are out in the open.
My thoughts only, but I like the way things are building for ACL.
- Forums
- ASX - By Stock
- TSN
- hyact upside
hyact upside
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online